Original ArticleA randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial
Under a Creative Commons license
open access
Graphical abstract
Keywords
anticoagulant agent
antiplatelet agent
COVID-19 infection
ischemic heart disease
randomized controlled trial
thrombosis
Cited by (0)
Funding information Coronary Flow Charitable Trust and Imperial College COVID-19 fund.
Manuscript handled by: Jean Connors
Final decision: Jean Connors, 01 May 2023
© 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.